Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 1/20 | 0.36 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.31 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.31 |
| ▸ | GABRP | O00591 | 1/20 | 0.30 |
| ▸ | GABRD | O14764 | 1/20 | 0.30 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.30 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.30 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.30 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.30 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.30 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.30 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.30 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.30 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.30 |
| ▸ | GABRE | P78334 | 1/20 | 0.30 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.30 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.30 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.30 |
| ▸ | GABRQ | Q9UN88 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4536424 | 0.81 | — | — | |
| SCHEMBL17110614 | 0.75 | FFAR4 (0.31) | — | |
| SCHEMBL17110660 | 0.75 | — | — | |
| SCHEMBL900073 | 0.75 | — | — | |
| SCHEMBL159421 | 0.73 | NQO1 (0.36) | — | |
| SCHEMBL17164316 | 0.73 | SCN4A (0.34) | — | |
| SCHEMBL17110672 | 0.71 | FFAR4 (0.31) | — | |
| SCHEMBL159542 | 0.70 | KMT2A (0.34) | MCHR1 | |
| SCHEMBL440263 | 0.70 | MCHR1 (0.34) | MCHR1GPBAR1CYSLTR1GABRPGABRD | |
| SCHEMBL160707 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3129358-A1 | DIAMINOTRIAZINE DERIVATIVES AS HERBICIDES | BASF SE (DE) | 2017-02-15 | — | — | EP | claimed |
| US-20170029383-A1 | Diaminotriazine Derivatives as Herbicides | BASF SE (DE) | 2017-02-02 | — | — | US | claimed |
| WO-2015155271-A1 | DIAMINOTRIAZINE DERIVATIVES AS HERBICIDES | BASF SE (DE) | 2015-10-15 | — | — | WO | claimed |
| US-20170101383-A1 | DIAMINOTRIAZINE DERIVATIVES AS HERBICIDES | BASF SE (DE) | 2017-04-13 | — | — | US | disclosed |
| EP-3129358-A1 | DIAMINOTRIAZINE DERIVATIVES AS HERBICIDES | BASF SE (DE) | 2017-02-15 | — | — | EP | disclosed |
| US-20170029383-A1 | Diaminotriazine Derivatives as Herbicides | BASF SE (DE) | 2017-02-02 | — | — | US | disclosed |
| EP-3122736-A1 | DIAMINOTRIAZINE DERIVATIVES AS HERBICIDES | BASF SE (DE) | 2017-02-01 | — | — | EP | disclosed |
| WO-2015155129-A1 | DIAMINOTRIAZINE COMPOUND | BASF SE (DE) | 2015-10-15 | — | — | WO | disclosed |
| WO-2015155271-A1 | DIAMINOTRIAZINE DERIVATIVES AS HERBICIDES | BASF SE (DE) | 2015-10-15 | — | — | WO | disclosed |
| WO-2015144881-A1 | DIAMINOTRIAZINE DERIVATIVES AS HERBICIDES | BASF SE (DE) | 2015-10-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170101383-A1 | DIAMINOTRIAZINE DERIVATIVES AS HERBICIDES | DRD3, CBR3, ATL3 | MCHR1 2517/4885GPBAR1 2070/4885CYSLTR1 3839/4885 |
| US-20170029383-A1 | Diaminotriazine Derivatives as Herbicides | DDT, CBR3, HDHD5 | MCHR1 2093/4885GPBAR1 2373/4885CYSLTR1 3232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.